Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Revenue: 2020-2025

Historic Revenue for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to $116.7 million.

  • GeneDx Holdings' Revenue rose 51.86% to $116.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $402.2 million, marking a year-over-year increase of 50.50%. This contributed to the annual value of $305.4 million for FY2024, which is 50.79% up from last year.
  • Latest data reveals that GeneDx Holdings reported Revenue of $116.7 million as of Q3 2025, which was up 13.68% from $102.7 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Revenue high stood at $116.7 million for Q3 2025, and its period low was $36.2 million during Q2 2022.
  • Its 3-year average for Revenue is $74.1 million, with a median of $70.5 million in 2024.
  • Per our database at Business Quant, GeneDx Holdings' Revenue soared by 92.77% in 2022 and then tumbled by 35.96% in 2023.
  • Over the past 5 years, GeneDx Holdings' Revenue (Quarterly) stood at $57.8 million in 2021, then rose by 6.14% to $61.4 million in 2022, then decreased by 6.41% to $57.4 million in 2023, then skyrocketed by 66.57% to $95.6 million in 2024, then surged by 51.86% to $116.7 million in 2025.
  • Its last three reported values are $116.7 million in Q3 2025, $102.7 million for Q2 2025, and $87.1 million during Q1 2025.